This is a preview of subscription content, log in via an institution to check access.
References
Lanzoprazole heals erosive reflux esophagitis better than Ranitidine. M. Robinson and all Abbott Laboratories, Abbott Park. IL, TAP Pharmaceuticals Inc., Deerfield, IL.
Lanzoprazole heals erosive reflux esophagitis resistant to histamine H2 receptor antagonist therapy. S. SONTAG. Hines Veterans Administration Hospital, Hines, IL, TAP Pharmaceuticals Inc., Deerfield, IL, Abbott Laboratories, Abbott Park, IL.
Omeprazole Treatment in children with peptic esophagitis refractory to Ranitidine. M. Karjoo, R.E. Kane, Department of Pediatrics, St Louis University School of Medicine, St Louis, MO.
Lanzoprazole versus Omeprazole in short-term treatment of reflux esophagitis. Results of a Scandinavian Multicentre Trial. J.C. Hatlebakk and al., Bergen Norway.
Alternate day Omeprazole Maintenance therapy in H2 RA resistant esophagitis-clinical, Gastrin 6 ECL effects for up to 3 years. S. BANK, N-Y.
Omeprazole 10 mg or 20 mg daily for the prevention of relapse in gastroesophageal reflux disease ? A double-blind comparative study. K. LAURISTEN. Odense, Denmark.
anitidine 150 mg bid prevents erosive esophagitis recurrences. A.R. EULER, R.H. MURDOCK, Research Triangle Park, NC.
Author information
Authors and Affiliations
About this article
Cite this article
Vandromme, L. Traitement médical de l’œsophagite peptique. Acta Endosc 22 (Suppl 2), 228–229 (1992). https://doi.org/10.1007/BF02966349
Issue Date:
DOI: https://doi.org/10.1007/BF02966349